WHO Draft Working Document on Bioanalytical Method Validation published for Comments
![Statistical Simulations for Enhanced Understanding of Analytical Performance - Live Webinar](files/eca/userImages/training.img/Z-ECA-Webinar-Statistical-Simulations.jpg)
Recommendation
Monday, 9 September 2024 14.00 - 16.00 h
The World Health Organization (WHO) has published a draft working document entitled Bioanalytical Method Validation and Study Sample Analysis (QAS/23.925).
Content
The "guideline is intended to provide recommendations for the validation of bioanalytical methods for chemical and biological drug quantification and their application in the analysis of study samples."
It is divided into the following main chapters:
- 1. Introduction
- 2. General principles
- 3. Chromatography
- 4. Ligand binding assays
- 5. Incurred Sample Reanalysis (ISR)
- 6. Partial and cross validation
- 7. Additional considerations
- 8. Documentation
- 9. Glossary
The text is based on the ICH M10 Guidline from May 2022.
Please also see the following articles in our news archiv for further information:
- ICH M10 Guideline on Bioanalytical Method Validation and Study Sample Analysis
- ICH M10 - Draft Guideline on Validation of Bioanalytical Methods published for public Comments
Download and Comments
You can download the document from the WHO Medicines website under "Working documents in public consultation".
Comments should be submitted by 21 January 2024. The WHO asks that comments should be submitted through the online platform PleaseReview™. Further information on the commenting process can be found on the first page of the new document.
Related GMP News
24.07.2024FDA Warning Letter to Chinese OTC Manufacturer for Lack of Analytical Test Data
10.07.2024Pharmeuropa: Two Revised Chapters on Dissolution Testing published for comments
03.07.2024FDA Warning Letter: GMP Requirements also apply to HPLC Analyses for Internal Use
12.06.2024NMPA Announcement on Application of ICH Q2(R2) and Q14 Principles
22.05.2024Q&As from the Live Online Training "Introduction to the AQCG's new AIQSV Guide" - Part 1
22.05.2024FDA Warning Letter to Contract Testing Laboratory in Uruguay due to Data Integrity Violations